Company profile
Centessa Pharmaceuticals PLC
Pipeline3 assets
- cleminorextonORX750 / OX2R / oral orexin receptor 2 agonist / Sleep-wake disordersNarcolepsy Type 1 (NT1)Phase 2aactiveNarcolepsy Type 2 (NT2)Phase 2aactiveIdiopathic Hypersomnia (IH)Phase 2aactive
- ORX142ORX142 / OX2R / oral orexin receptor 2 agonist / Neurology/neurodegenerative disordersNeurological & neurodegenerative disordersPhase 1active
- ORX489ORX489 / OX2R / oral orexin receptor 2 agonist / NeuropsychiatryNeuropsychiatric disordersPreclinicalactive
Latest news0 items
All newsNo recent headlines yet.
New company coverage will appear here as soon as it is picked up.